Home / Fellowships / Research Fundings / Infectious Disease Research Funding Opportunity Announcement 2017
Infectious Disease Research Funding Opportunity Announcement 2017

Infectious Disease Research Funding Opportunity Announcement 2017

Infectious Disease Research Funding Opportunity Announcement 2017 : This Funding Opportunity Announcement (FOA) encourages applications from organizations/institutions in eligible foreign countries that propose research related to infectious diseases that are of interest/importance to that countryInfectious Disease Research Funding Opportunity Announcement 2017

Infectious Disease Research Funding Opportunity Announcement 2017

Key Dates

Posted Date: January 27, 2017

Open Date (Earliest Submission Date): April 22, 2017

Letter of Intent Due Date(s)
New Date: 30 days prior to the application due date

Application Due Date(s)

May 22, 2017; May 22, 2018; May 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Infectious Disease Research Funding Opportunity Announcement 2017

AIDS Application Due Date(s)

August 22, 2017; August 22, 2018; August 22, 2019, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review: October 2017; October 2018; October 2019

Advisory Council Review: January 2018; January 2019; January 2020

Earliest Start Date: March 2018; March 2019; March 2020

Expiration Date: August 23, 2019

Due Dates for E.O. 12372: Not Applicable

Infectious Disease Research Funding Opportunity Announcement 2017

Required Application Instructions
It is critical that applicants follow the Research (R) Instructions in the SF424 (R&R) Application Guide, except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.

There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners.

Use the NIH ASSIST system to prepare, submit and track your application online.
Apply Online Using ASSIST

Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and eRA Commons to track your application. Check with your institutional officials regarding availability.

Go to Grants.gov to download an application package to complete the application forms offline or create a Workspace to complete the forms online; submit your application to Grants.gov; and track your application in eRA Commons.
Learn more about the various submission options.

Infectious Disease Research Funding Opportunity Announcement 2017

Table of Contents

Part 1. Overview Information
Part 2. Full Text of the Announcement

Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information

 Research Objectives and Scope

Studies may be proposed on any aspect of infectious disease research (except clinical trials), including but not limited to: the epidemiology, natural history, pathogenesis, immunopathogenesis of infectious diseases; epidemiologic studies to define the incidence, clinical presentations, and outcomes of diseases; identification of resistance mechanisms and patterns; characterization of susceptible cohorts for a particular pathogen; pilot and feasibility studies in preparation for larger studies. NOTE: HIV/AIDS studies must address NIAID priorities described at http://www.niaid.nih.gov/about/division-aids-overview

Collaborative projects involving investigators and institutions from international sites and the U.S. are particularly encouraged; however, a U.S. partner is not required. NIH supports a number of international research programs on infectious diseases, including HIV/AIDS. For NIAID, these include the International Centers of Excellence in Research (ICERs), International Collaborations in Infectious Disease Research (ICIDRs), the Tropical Medicine Research Centers (TMRCs), the Centers of Excellence for Influenza Research and Surveillance (CEIRS), the International Centers of Excellence for Malaria Research (ICEMRS), the Tuberculosis Research Unit, the HIV Vaccine Trials Network (HVTN), the HIV Prevention Trials Network (HPTN), International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT), AIDS Clinical Trials Group (ACTG), Microbicide Trials Network (MTN), the International Epidemiologic Database to Evaluate AIDS (IeDEA), and the Centers for AIDS Research (CFAR).

This International Research in Infectious Diseases including AIDS (IRIDA) Program is intended to extend these programs by expanding the breadth of research supported at international sites and by providing support to new researchers. Applications are particularly encouraged from institutions in eligible countries where NIH has significant investments through extramural research grants, cooperative agreements or contracts or through NIH intramural programs. Current NIH or NIAID funding is not a requirement.

Applicants are strongly encouraged to establish multi-institutional collaborations and to include activities that involve the transfer of technologies and research methods, sharing of core resources including the administration of research grant programs, and expansion of linkages to other sites via attendance at national and international meetings and other methods of communication.

Note: Clinical trials will not be supported. When non-interventional clinical studies using human subjects are an element of the research proposed, NIAID policy requires that studies be monitored commensurate with the degree of potential risk to study subjects and the complexity of the study. Guidance regarding policies and standard procedures for conducting NIAID-funded and/or -sponsored clinical research can be found at the following link: https://www.niaid.nih.gov/research/dmid-clinical-research-policies or https://www.niaid.nih.gov/research/daids-clinical-research-policies-standard-procedures.

Note: Select Agents Research will not be supported. Select Agents are biological agents or toxins listed in 42 CFR Part 73, 7 CFR Part 331 and 9 CFR Part 121, or the HHS and USDA Select Agents and Toxins List.

See Section VIII. Other Information for award authorities and regulations.

Infectious Disease Research Funding Opportunity Announcement 2017

View Original Notification: https://grants.nih.gov/grants/guide/pa-files/PAR-17-142.html

Check Also

SEARCA 2017 Seed Fund Research& Training Fellowship in Southeast Asia

SEARCA 2017 Seed Fund Research& Training Fellowship in Southeast Asia

SEARCA 2017 Seed Fund Research & Training Fellowship in Southeast Asia: The Southeast Asian Regional …

BioChem Adda is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad-blocker.
%d bloggers like this: